PPARG and early-onset autosomal dominant Alzheimer disease: Activation of PPARγ signaling has a protective role by reducing neuroinflammation [42], a finding which may present a novel therapeutic approach for diseases, including Alzheimer’s disease [20, 43], Parkinson’s disease [24, 44], stroke [45], schizophrenia, and autism [22].